NVAX

Novavax, Inc.$9.42+0.64% 1D· price as of Jun 30, 8:32 PM

Universe

+47.88% over 1Y

Compare:NVAX

Mkt Cap

$1.5B

P/E

—

Fwd P/E

—

PEG

1.32

P/B

—

P/S

2.6×

EV/EBITDA

17.7×

Beta

2.41

Div Yield

—

Payout

0.0%

ROE

—

Net Margin

-14.7%

Short % Flt

31.9%

Inst. Own

69.6%

52-wk low $6.20$9.4252-wk high $11.97

+51.9% above low-21.3% from high

Seasonality — avg monthly return

Strongest May 47.6% · weakest Dec -18.9%

Jan

+15.5

Feb

+2.1

Mar

-17.4

Apr

-0.9

May

+47.6

Jun

-2.5

Jul

+4.4

Aug

-2.2

Sep

-9.9

Oct

-8.2

Nov

-5.7

Dec

-18.9

Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.

Ask AI about Novavax, Inc.

Gemini · web search

Searches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.

NVAX — recent news

Loading headlines…